EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Network Pharmacology and Molecular Docking Identify Medicarpin as a Potent CASP3 and ESR1 Binder Driving Apoptotic and Hormone-Dependent Anticancer Activity

Yanisa Rattanapan iD, Sirinya Sitthirak iD, Aman Tedasen, Thitinat Duangchan iD, Hasaya Dokduang iD, Nawanwat C Pattaranggoon iD, Krittamate Saisuwan iD, Takol Chareonsirisuthigul iD

International Journal of Molecular Sciences · 23.12.2025 · 27 (1) · 174

DOI: 10.3390/ijms27010174 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 23.12.2025. Verfasst von Yanisa Rattanapan und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Technology, School of Allied Health Sciences, Walailak University, Nakhon Si Thammarat 80160, Thailand. Hauptthemen laut MEDLINE: Apoptosis, Estrogen Receptor alpha, Caspase 3, Antineoplastic Agents. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Ovarian cancer (OC) remains one of the most lethal gynecologic malignancies due to late diagnosis, rapid progression, and frequent chemoresistance. Despite advances in targeted therapy, durable responses are uncommon, underscoring the need for novel multitarget agents capable of modulating key oncogenic networks. Medicarpin, a natural pterocarpan phytoalexin, exhibits diverse pharmacological activities; however, its molecular mechanisms in OC are poorly defined. This study employed an integrative in silico framework combining network pharmacology, pathway enrichment, molecular docking, and survival analysis to elucidate medicarpin’s therapeutic landscape in OC. A total of 107 overlapping targets were identified, resulting in a dense protein–protein interaction network enriched in kinase-mediated and apoptotic signaling pathways. Ten hub genes were emphasized: CASP3, ESR1, mTOR, PIK3CA, CCND1, GSK3B, CDK4, PARP1, CHEK1, and ABL1. Gene Ontology and KEGG analyses demonstrated substantial enrichment in the PI3K–Akt/mTOR and prolactin signaling pathways. Docking revealed the stable binding of medicarpin to CASP3 (−6.13 kcal/mol) and ESR1 (−7.68 kcal/mol), supporting its dual regulation of hormonal and apoptotic processes. Although CASP3 and ESR1 expression alone lacked prognostic significance, their network interplay suggests synergistic relevance. Medicarpin exhibits multitarget anticancer potential in OC by modulating kinase-driven and hormone-dependent pathways, warranting further experimental validation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ApoptosisEstrogen Receptor alphaCaspase 3Antineoplastic AgentsHumansMolecular Docking SimulationNetwork PharmacologyFemaleSignal TransductionProtein Interaction MapsProtein Binding

Stichwörter der Autor:innen

CASP3ESR1PI3K-Akt/mTOR pathwaymedicarpinmolecular dockingnetwork pharmacologyovarian cancer

Substanzen

Estrogen Receptor alphaCaspase 3ESR1 protein, humanAntineoplastic Agents

Autor:innen und Institutionen

  • Department of Medical Technology, School of Allied Health Sciences, Walailak University, Nakhon Si Thammarat 80160, Thailand.
  • Hematology and Transfusion Science Research Center (HTSRC), Walailak University, Nakhon Si Thammarat 80160, Thailand.
  • Research Excellence Center for Innovation and Health Products (RECIHP), Walailak University, Nakhon Si Thammarat 80160, Thailand.
  • Faculty of Medicine, Mahasarakham University, Mahasarakham 44000, Thailand.
  • Cholangiocarcinoma Research Institute, Khon Kaen University, Khon Kaen 40002, Thailand.
  • Faculty of Medical Technology, Rangsit University, Muang 12000, Thailand.

ORCID-Profile: Yanisa Rattanapan, Sirinya Sitthirak, Thitinat Duangchan, Hasaya Dokduang, Nawanwat C Pattaranggoon, Krittamate Saisuwan, Takol Chareonsirisuthigul

Zitieren

APA

Rattanapan, Y., Sitthirak, S., Tedasen, A., Duangchan, T., Dokduang, H., Pattaranggoon, N. C., Saisuwan, K., & Chareonsirisuthigul, T. (2025). Network Pharmacology and Molecular Docking Identify Medicarpin as a Potent CASP3 and ESR1 Binder Driving Apoptotic and Hormone-Dependent Anticancer Activity. International Journal of Molecular Sciences, 27(1), 174. https://doi.org/10.3390/ijms27010174

Vancouver

Rattanapan Y, Sitthirak S, Tedasen A, Duangchan T, Dokduang H, Pattaranggoon NC, et al. Network Pharmacology and Molecular Docking Identify Medicarpin as a Potent CASP3 and ESR1 Binder Driving Apoptotic and Hormone-Dependent Anticancer Activity. International Journal of Molecular Sciences. 2025;27(1):174. doi:10.3390/ijms27010174

BibTeX
@article{Rattanapan2025,
  author = {Rattanapan, Yanisa and Sitthirak, Sirinya and Tedasen, Aman and Duangchan, Thitinat and Dokduang, Hasaya and Pattaranggoon, Nawanwat C and Saisuwan, Krittamate and Chareonsirisuthigul, Takol},
  title = {Network Pharmacology and Molecular Docking Identify Medicarpin as a Potent CASP3 and ESR1 Binder Driving Apoptotic and Hormone-Dependent Anticancer Activity},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  volume = {27},
  number = {1},
  pages = {174},
  doi = {10.3390/ijms27010174}
}
Kostenlos starten →